Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 14, 2023

BUY
$9.02 - $10.29 $99,923 - $113,992
11,078 New
11,078 $110,000
Q2 2022

Aug 09, 2022

SELL
$9.95 - $12.27 $1,562 - $1,926
-157 Reduced 1.36%
11,427 $120,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $6,484 - $10,179
-661 Reduced 5.4%
11,584 $126,000
Q4 2021

Feb 11, 2022

SELL
$12.09 - $14.68 $9,925 - $12,052
-821 Reduced 6.28%
12,245 $166,000
Q3 2021

Nov 16, 2021

SELL
$13.25 - $15.13 $11,593 - $13,238
-875 Reduced 6.28%
13,066 $177,000
Q2 2021

Aug 12, 2021

BUY
$12.97 - $16.15 $13,060 - $16,263
1,007 Added 7.79%
13,941 $199,000
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $43,664 - $59,569
-3,213 Reduced 19.9%
12,934 $181,000
Q4 2020

Feb 09, 2021

BUY
$14.3 - $18.74 $230,902 - $302,594
16,147 New
16,147 $303,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Sea Crest Wealth Management, LLC Portfolio

Follow Sea Crest Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.